ATP6V1G1
V-type proton ATPase subunit G 1
Also known as: ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, VATG1_HUMAN, Vma10
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75348
- Gene
- ATP6V1G1
- Ensembl
- ENSG00000136888
- Chromosome
- 9
- Canonical length
- 118 aa
- Protein class
- Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. The protein encoded by this gene is one of three V1 domain G subunit proteins. Pseudogenes of this gene have been characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
118 residues, UniProt reviewed canonical sequence.
>O75348|ATP6V1G1
1 MASQSQGIQQ LLQAEKRAAE KVSEARKRKN RRLKQAKEEA QAEIEQYRLQ REKEFKAKEA
61 AALGSRGSCS TEVEKETQEK MTILQTYFRQ NRDEVLDNLL AFVCDIRPEI HENYRINGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP6V1G1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 167 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 167 nTPM
- parathyroid gland: 162 nTPM
- adrenal gland: 132 nTPM
- kidney: 127 nTPM
- prostate: 125 nTPM
- bone marrow: 124 nTPM
Single-cell type
- esophageal apical cells: 2,352 nCPM
- parietal cells: 1,296 nCPM
- gastric chief cells: 1,090 nCPM
- syncytiotrophoblasts: 1,075 nCPM
- esophageal suprabasal cells: 874 nCPM
- epididymal principal cells: 830 nCPM
Immune cell
- total PBMC: 758 nTPM
- memory B-cell: 552 nTPM
- naive B-cell: 505 nTPM
- eosinophil: 497 nTPM
- basophil: 491 nTPM
- neutrophil: 407 nTPM
Brain region
- choroid plexus: 71 nTPM
- pons: 61 nTPM
- hypothalamus: 59 nTPM
- midbrain: 59 nTPM
- thalamus: 52 nTPM
- medulla oblongata: 50 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- -0.94
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to increased oxygen levels
- intracellular iron ion homeostasis
- regulation of macroautophagy
- synaptic vesicle lumen acidification
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP6V1G1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP6V1G1 as an antibody target. Whether an autoantibody or antibody against ATP6V1G1 could matter depends on whether native ATP6V1G1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP6V1G1 is annotated at the cell surface, where native ATP6V1G1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP6V1G1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...